ResMed (RMD) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $191.26 --0%
Revenue Growth %: +13.1%
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +13.1%
Financial Fact:
Income from operations: 94.15M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $0.65, in-line with the analyst estimate of $0.65. Revenue for the quarter came in at $422.5 million versus the consensus estimate of $425.76 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)
- KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
